Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply

February 5, 2024 admin-dominor

[ad_1]

Catalent is the main supplier of fill-finish work, which involves filling and packaging syringes and injection pens, for Novo Nordisk's Wegovy.

[ad_2]

Source link

Thoma Bravo takes critical event management software company Everbridge private in $1.5B deal | TechCrunch
US strikes in the Middle East will not change Biden’s re-election fortunes

You May Also Like

Cash vs. stocks: The pros weigh in on where to invest for the rest of the year

This asset can provide investors hefty yields at a favorable tax rate. Here’s what you should know

Investors are holding near-record levels of cash and may be poised to snap up stocks